{"id":13230,"date":"2024-02-14T16:41:27","date_gmt":"2024-02-14T15:41:27","guid":{"rendered":"https:\/\/initial.mentalworks.me\/realisations\/cellularis-discovery-earlysight\/"},"modified":"2026-03-19T19:03:19","modified_gmt":"2026-03-19T18:03:19","slug":"cellularis-discovery-earlysight","status":"publish","type":"realisation","link":"https:\/\/initial.mentalworks.me\/en\/achievements\/cellularis-discovery-earlysight\/","title":{"rendered":"An eye on the future – The Cellularis Discovery device by EarlySight"},"content":{"rendered":"
\n
\n\n \n
\n \n \"earlysight\n <\/picture>\n <\/div>\n
\n
\n
\n Cellularis Discovery by Earlysight<\/span>\n

The ophthalmology revolution is in full swing…<\/h2>\n <\/div>\n
\n

Led by EarlySight<\/a>, an ambitious Swiss start-up.<\/p>\n

A spin-off of the Swiss Federal Institute of Technology in Lausanne (EPFL)<\/a>, the start-up, founded in 2019, brings together professors and graduates seeking to improve the care of patients with retinal diseases, including AMD (which affects more than 67 million people around the world).<\/p>\n\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\n\n

\n
\n
\n Earlysight<\/span>\n <\/div>\n
\n

A start-up looking to revolutionise the treatment of ocular diseases<\/strong><\/h2>\n\n <\/div>\n <\/div>\n <\/div>\n\n\n
\n
\n\n \n
\n
\n
\n

The design of an innovative device<\/h2>\n <\/div>\n
Current technologies used in hospital environments have not allowed the microscopic structures of the eye to be observed. As a result, diagnosis has been incomplete.<\/div>\n
\n

In response to this issue, the EarlySight team has designed a revolutionary imaging device known as Cellularis\u00ae Discovery<\/a>. This new high-precision optical imaging device enables a number of ocular structures, which were previously invisible using conventional transpupillary illumination, to be examined on a cellular level. The ongoing development of AI software will soon make it possible to quantitatively measure the structures affected early in diseases, such as the retinal pigment epithelium.<\/p>\n

Its aim is to accurately detect and monitor the biomarkers of ocular diseases, in order to prevent them.<\/p>\n\n <\/div>\n <\/div>\n <\/div>\n

\n \n \"earlysight\n <\/picture>\n \u00a9 \u00a9Earlysight<\/span>\n <\/div>\n <\/div>\n <\/div>\n\n\n
\n
\n\n \n
\n \n \"earlysight\n <\/picture>\n \u00a9 Dispositif m\u00e9dical Impression 3D<\/span>\n <\/div>\n
\n
\n
\n

The desire for a fresh look at the appearance of medical devices illustrated by K.I.D.S<\/h2>\n <\/div>\n
The start-up wants Cellularis\u00ae Discovery to be innovative in terms of both technology and design. So particular attention has been paid to the appearance of the device, in an attempt to step outside the usual rules governing the medical world.<\/div>\n
\n

EarlySight worked with the design agency K.I.D.S<\/a> (Knowledge. Intensive. Design. Service), to make its vision a reality. The agency\u2019s values, with the focus on human-centred product design, align perfectly with the desire of engineers to create a practical and convenient device, from the point of view of both practitioners and patients.<\/p>\n\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n\n\n

\n
\n\n \n
\n
\n
\n

A collaboration combining aesthetics and high-tech engineering<\/h2>\n <\/div>\n
<\/div>\n
\n

The product design office<\/a> INITIAL worked closely with K.I.D.S to rethink and reshape this pioneering device\u2019s design.<\/strong><\/p>\n

The aim was to envelop the technology simply by playing with reassuring materials and lines, while optimising the ergonomics for both professionals and patients. INITIAL designed and assembled each part, as well as carrying out the final build, with a specific technical development for securing components and their interface.<\/p>\n\n <\/div>\n <\/div>\n <\/div>\n

\n \n \"earlysight\n <\/picture>\n \u00a9 initial – medical device 3D printing<\/span>\n <\/div>\n <\/div>\n <\/div>\n\n\n
\n
\n
\n

3D printing at the core of the project: From design to assembly<\/h2>\n <\/div>\n
The EarlySight team wanted their innovative machine to be designed with technology allowing an ergonomic, flexible and robust housing to be produced. INITIAL supported the team from prototyping to industrialisation, by offering them a combination of several technologies, allowing them to create a device that fulfilled their requirements with the maximum comfort.<\/div>\n
\n

There are more than 40 components at the heart of the device, highlighting the crucial role of 3D printing in its design and production. Economic suitability and technical feasibility were the key factors guiding 3D technological choices and the variety of materials<\/a> used, including powder, resin and PolyJet 3D printing, as well as numerous flexible and rigid materials.<\/p>\n\n <\/div>\n <\/div>\n <\/div>\n\n\n

\n
\n\n \n
\n \n \"earlysight\n <\/picture>\n \u00a9 initial – medical device 3D printing<\/span>\n <\/div>\n
\n \n \"earlysight\n <\/picture>\n \u00a9 initial – medical device 3D printing<\/span>\n <\/div>\n <\/div>\n <\/div>\n\n\n
\n
\n
\n

Promising technology<\/h2>\n A first series of 14 machines is currently being delivered, marking a turning point in the prevention of retinal diseases.<\/span>\n <\/div>\n
\n

The Cellularis\u00ae Discovery device has recently obtained CE certification<\/a>, underlining the product\u2019s reliability and safety in the medical field.<\/strong><\/p>\n

The collaboration between INITIAL, EarlySight and K.I.D.S perfectly illustrates how 3D printing<\/a> technology is able to transform the medical sector<\/a>. With a unique design, cutting-edge technology and carefully orchestrated production, this collaboration paves the way for new advances in the field of ophthalmology and beyond.<\/p>\n\n <\/div>\n <\/div>\n <\/div>\n\n\n

\n
\n
\n

Your Challenges \/\/ Our Productions<\/h2>\n For every challenge, benefit from our technological solutions and our service and support capabilities to meet your most demanding applications.<\/span>\n <\/div>\n
\n
\n
\n
\n \n \"Initial\n <\/picture>\n
\n

Mahi prosthetic foot based on a biomechanical approach<\/h2>\n
\n Exoneo is at the forefront of innovative solutions designed to revolutionize and improve human mobility.\n <\/div>\n Learn more<\/a>\n <\/div>\n <\/div>\n
\n \n \"emboiture\n <\/picture>\n
\n

Made-to-measure devices thanks to 3D printing<\/h2>\n
\n A high-performance, comfortable and aesthetically pleasing appliance redesigned by OPR to suit every patient.\n <\/div>\n Learn more<\/a>\n <\/div>\n <\/div>\n
\n \n \"initial\n <\/picture>\n
\n

The secrets of the Spirgrips\u00ae ergonomic handle<\/h2>\n
\n Handles capable of offering an alternative position on the handlebars while correctly aligning the forearm joints.\n <\/div>\n Learn more<\/a>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n","protected":false},"excerpt":{"rendered":"

Earlysight, a start-up aiming to revolutionize the treatment of eye diseases, has designed a revolutionary imaging device called Cellularis\u00ae Discovery, in collaboration with design firm KIDS and Initial’s teams.<\/p>\n","protected":false},"featured_media":13204,"template":"","realisation_tags":[],"class_list":["post-13230","realisation","type-realisation","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/initial.mentalworks.me\/en\/wp-json\/wp\/v2\/realisation\/13230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/initial.mentalworks.me\/en\/wp-json\/wp\/v2\/realisation"}],"about":[{"href":"https:\/\/initial.mentalworks.me\/en\/wp-json\/wp\/v2\/types\/realisation"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/initial.mentalworks.me\/en\/wp-json\/wp\/v2\/media\/13204"}],"wp:attachment":[{"href":"https:\/\/initial.mentalworks.me\/en\/wp-json\/wp\/v2\/media?parent=13230"}],"wp:term":[{"taxonomy":"realisation_tags","embeddable":true,"href":"https:\/\/initial.mentalworks.me\/en\/wp-json\/wp\/v2\/realisation_tags?post=13230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}